You are in: eMedicine Specialties > Urology > Urologic Imaging Urologic Imaging Without X-rays: Ultrasound, MRI, and Nuclear MedicineArticle Last Updated: Jan 4, 2007AUTHOR AND EDITOR INFORMATIONAuthor: Andrew C Peterson, MD, FACS, Assistant Professor of Surgery, Uniformed Services University; Chief, Reconstructive Urology, Female Urology and Urodynamics, Residency Program Director, Department of Surgery, Section of Urology, Madigan Army Medical Center Andrew C Peterson is a member of the following medical societies: American College of Surgeons, American Urological Association, and Western Section American Urological Association Coauthor(s): Martha K Terris, MD, FACS, Professor, Department of Surgery, Medical College of Georgia Editors: Edmund S Sabanegh, MD, Director, Center for Male Fertility, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Martin I Resnick, MD , Former Lester Persky Professor and Chair, Department of Urology, Former Professor, Department of Oncology, Case Western Reserve University School of Medicine; J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center; Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio Author and Editor Disclosure Synonyms and related keywords: ultrasound, sonography, ultrasonography, gray-scale imaging, Doppler imaging, Doppler study, ProstaScint, capromab pendetide, MRI, magnetic resonance imaging, MR imaging, nuclear magnetic imaging, nuclear imaging, scintigraphy, nucleotide imaging, transrectal ultrasound, TRUS, transvaginal ultrasound, imaging studies, imaging study, diagnostic imaging, ultrasound diagnosis, MRI diagnosis, nuclear imaging diagnosis UROLOGIC ULTRASOUNDUltrasonography was initially developed as a military tool and was adopted by the medical world after World War II. In 1961, Schlegel et al first reported the usefulness of sonography in urology, for the detection of renal calculi. Ultrasonography is mainly performed by radiologists. However, nonradiologist clinicians commonly perform and interpret specific types of ultrasound (eg, obstetricians, fetal ultrasound; urologists, transrectal ultrasound [TRUS] of the prostate). The ideal ultrasound examination is one in which the clinician interprets it in real time while it is being performed. Therefore, physicians should observe ultrasound studies during the examination. For excellent patient education resources, visit eMedicine's Imaging Center and Cancer and Tumors Center. Also, see eMedicine's patient education articles Magnetic Resonance Imaging (MRI) and Bladder Cancer. Ultrasound Equipment and PhysicsAn ultrasound probe is a housing structure for an ultrasound transducer and the associated wiring for connection to a console with a computer. The probe is shaped for the desired application, eg, cylindrical for endorectal use. The transducer generates high-frequency sound waves (typically 5-10 MHz) and directs them through body tissues by means of a probe held against the skin. Various probes and transducers are available for examination of different organs and body parts. The probe also contains a receiver to detect sound waves (called echoes) reflected from tissues. Through a process called acoustic-electric conversion, the transducer transforms the sound energy into electrical energy. The electrical energy is processed by the computer in the ultrasound console to generate an image of minute white dots (pixels) corresponding to the returning signals. Displayed on a black background, the white pixels produce an image of assorted shades of gray. When the sound waves travel easily through uniform substances (eg, water, oil, urine), no echoes are generated. The ultrasound image seen on the screen is therefore black; no echoes are present. When the sound waves encounter tissues of different densities, the sound waves are absorbed, reflected back to the probe, or transmitted through the tissue at different velocities. When this happens, the ultrasound image is white or gray depending on the intensity of the reflection. Unlike x-ray films or CT scans, ultrasound does not detect tissue density. Rather, it detects sonotransmission (the passage or reflection of sound). Highly dense tissues, such as bone or kidney stones, readily reflect echoes and, therefore, appear bright white on an ultrasound image. Air, such as in the bowel, also readily reflects echoes, so the edge of the bowel appears white on an ultrasound image. Thus, substances with widely differing densities (eg, air, bone) may appear bright white on an ultrasound image. The range of gray shades generated lends this imaging technique the alternative label "gray-scale imaging," which distinguishes it from color Doppler ultrasonography. Sound waves are emitted and received by transducers in a single, narrow band. In order to produce a recognizable image, the transducer must be swept across the area of interest, producing multiple bands that are combined to form an image. The system for moving the transducer is called the scanner. As the speed at which the scanner sweeps across the imaged area decreases, resolution increases. Coupling medium The acoustic properties of soft tissue are very similar to those of water, but air is distinctly different; the presence of air between the probe and the tissue of interest can distort or obscure the image. For this reason, a water-density substance, termed a coupling medium, is used for transmission of the ultrasound image. This coupling medium is usually a sonographic jelly or lubricant and should be placed between the probe and the skin surface. Artifacts The computer within the ultrasound console is designed with the assumption that ultrasound signals propagate through tissue at a constant velocity and reflect back to the transducer in a narrow, straight line. In fact, the velocity and angle of ultrasound wave propagation is affected by different tissue density, the rate of change in these tissue densities (abrupt vs gradual), and the dimensions and configuration of the transducer. Such variations can lead to deviation of the ultrasound signals from the assumed direction of propagation, creating artifacts. Kossoff cautions that a feature should not be considered by the examiner to be real simply because it is displayed sonographically until it is appropriately evaluated from various angles. Conversely, a feature that is not displayed is not necessarily absent. Shadowing can occur due to intense reflectors such as calcifications or air, and increased through-enhancement is exhibited with fluid-filled structures such as cysts. Reverberation is an artifact caused by the ultrasound signal striking a very echogenic surface near the ultrasound transducer. This signal is ricocheted back and forth between the transducer and the reflector. An image representing the echogenic structure is accurately produced on the monitor, but each subsequent reflection of the sound wave back and forth, which takes twice as long to reach the transducer as the prior reflection, is interpreted by the transducer as another structure. This results in artifactual images, equally spaced, distal to the original reflector, and of decreasing intensity. In TRUS imaging, this effect is usually produced by the rectal wall and condom covering the probe and results in multiple hyperechoic arches evenly spaced between the rectal wall and the anterior aspect of the image. Such an effect can be minimized by using copious amounts of coupling medium and ensuring that no air is between the probe and the rectum. Phase cancellation of the ultrasound signal can occur when the signal laterally strikes a curved structure, reflecting the signal laterally away from the transducer. The transducer interprets this absence of signal as an absence of tissue, which results in a lack of echoes on the image. In TRUS imaging, this artifact is often encountered during transverse sector scanning of large prostates. The sound waves striking the curve of the posterolateral margin of the prostate are scattered, resulting in a hypoechoic shadow extending anteriorly and laterally from this edge of the prostate. Similar shadows can also be generated by the posterolateral margin of the transition zone (TZ), resulting in additional shadows. These shadows can be minimized by centering the probe under the lateral portions of the gland when inspecting this area of the prostate. Lateral and anterior refraction, also called dispersion or scatter, of the ultrasound signals is spread in a fanlike configuration away from the central portion of the image. Anterior refraction is not a significant problem in TRUS imaging of the prostate because the gland is relatively close to the transducer. Lateral refraction during sector scanning results in elongation of the lateral aspect of the image, creating a more bean-shaped image of the prostate than the actual spherical configuration of the gland. Renal UltrasoundNormal appearance The cortex (the periphery of the kidney tissue) is seen as gray with some darker circles spaced uniformly around the edge. These darker circles correspond to the renal pyramids. A dromedary hump, the incidental finding of an extra mass of normal renal cortex tissue only on the lateral portion of the left kidney, is a normal variant. Relative to the liver parenchyma, the kidney is isoechoic (the same shade of gray) or slightly hypoechoic (a darker shade of gray). The liver is superior to the kidney and superficial (towards the top of the image). It is rather homogeneous (with a fairly regular gray pattern). The kidney is not as homogeneous. These 2 organs can be compared to determine if renal medical disease is present. The center, or hilum, of the kidney contains multiple structures, such as the renal pelvis, blood vessels, nerves, fat, and lymphatics. The fat of the renal sinus is particularly echogenic (bright white). These structures transmit sound differently, and, as the sound waves hit these interfaces between 2 such structures, an echo is generated. Because of this, the renal hilum has increased echogenicity. A prominent column of Bertin is partial hypertrophy of the renal cortex protruding into the renal sinus, and this is another normal variant. The upper pole of the kidney, particularly on the left, can sometimes be hidden behind rib shadows. This fact makes it very important for the sonographer to use breathing techniques and multiple windows to visualize the entire kidney. Doppler ultrasound examination is a useful adjunct to renal sonography. Color Doppler imaging can reveal whether blood flow to an area of tissue is increased, decreased, or normal, narrowing the differential diagnosis. In addition to the presence of blood flow, a waveform tracing can be generated to show the nature of the flow throughout the cardiac cycle. Normally, a renal waveform tracing shows a rapid rise to a peak during systole and a slow fall to a plateau during diastole. The tracing remains above the baseline throughout, indicating flow throughout systole and diastole. The resistive index is a ratio and is essentially a measure of the end-diastolic flow in the arterial system (resistive index = [peak systolic - end diastolic]/peak systolic). Typical resistive index is 70%. The higher the resistive index, the higher the downstream resistance. A resistive index higher than 90% is definitely abnormal and suggests the possibility of renal artery stenosis. A high resistive index can also indicate ureteral obstruction and may serve as an indirect sign for a ureteral stone. Power Doppler is significantly more sensitive to flow than standard color Doppler and can demonstrate blood flow on the arteriolar level. Obstruction Ultrasound is the initial imaging modality of choice in any patient with an unexplained elevation of the creatinine level or recent onset of renal dysfunction. In most instances, the screening ultrasound images in the setting of acute renal failure are normal. Certain risk factors, such as prior obstruction, recent surgery, and pelvic neoplasms, can increase the likelihood of finding an obstructed kidney. The crucial finding of obstruction in renal ultrasound is renal pelvis and calyceal dilation characterized by effacement of the renal sinus fat by an anechoic-branched structure with posterior enhancement and through-transmission. This dilation involving the calyces and renal pelvis is termed hydronephrosis or pelvocaliectasis. Dilation of the ureter is referred to as hydroureter. Combined ureteral and renal pelvic dilation can be called hydroureteronephrosis. The degree of collecting system dilation is graded subjectively based on ultrasound findings; however, these terms are most useful in the serial follow-up care of a given patient. Mild dilation can be associated with complete obstruction, and marked dilation can be present without any accompanying obstruction. The size of the kidney and ureteral findings on ultrasound may aid in diagnosing the etiology of hydronephrosis. Hydronephrosis may be caused by obstruction (eg, ureteropelvic junction obstruction, stones) or by other causes (vesicoureteral reflux). Renal size is important because significant chronic obstruction can result in postobstructive renal atrophy. The presence of a dilated ureter may help to identify the location of any obstruction. Assess the kidney and visualized ureter for possible calculi. Transrectal or transvaginal scanning may aid in the identification of distal ureteral calculi. The ultrasonographer should look for and identify the presence of ureteral jets in the bladder to rule out obstruction. Further studies may be required to determine whether the dilation is functionally significant; a diuretic nuclear renal scan is the most common functional study used to make this distinction. Findings that can be confused with hydronephrosis due to obstruction include an extrarenal pelvis, prominent renal vasculature, residual dilation from previous obstruction, dilation as a result of ureterovesical reflux, congenital megacalices, papillary necrosis, pyelonephritis, distended urinary bladder, diabetes insipidus, and other, less-common causes. Pregnant women, patients who have undergone surgical repair of anatomic obstruction, and patients with urinary diversion or urinary stents normally display some degree of dilation of the collecting system, making the diagnosis of hydronephrosis due to obstruction particularly difficult in these patients. In contrast, obstruction can be present in the absence of hydronephrosis, in conditions such as early acute obstruction, hypovolemia, retroperitoneal metastases, and retroperitoneal fibrosis. Medical renal disease Renal disease caused by glomerulonephritis or systemic illnesses, such as diabetes, hypertension, arteriosclerosis, or autoimmune diseases, results in kidneys that are hyperechoic (brighter gray) compared to the adjacent liver parenchyma. Also, the kidneys are often smaller than normal. Pyelonephritis sonography In most cases of acute pyelonephritis, ultrasound images of the kidneys appear normal, with sensitivity for detecting cortical inflammation that is lower than CT scan or radionucleotide imaging. However, sonography can be very useful for detecting inciting or exacerbating abnormalities such as stones, hydronephrosis, or cysts. Mild hydronephrosis may be associated with uncomplicated pyelonephritis due to diminished ureteral peristalsis. Ultrasound is the imaging modality of choice for acute pyelonephritis in pregnant women. Renal enlargement and compression of the renal sinuses can be detected sonographically in severe cases of pyelonephritis. Ill-defined areas of hypoechogenicity may be seen, due to edema, or areas of hyperechogenicity may be present, due to hemorrhage. These changes may be accompanied by effacement of the corticomedullary boundaries. Ultrasound can be used to detect and monitor the progress of focal inflammatory masses and to evaluate complications of pyelonephritis, such as renal abscesses or pyohydronephrosis. Emphysematous pyelonephritis is characterized by gas within the renal parenchyma due to infection with gas-forming bacteria. Sonography shows hyperechoic foci with vague shadowing and distortion of the renal sinus because of the presence of air in the system. Ultrasound often underestimates the extension of the infection because structures deep to the gas collections are obliterated. As a result, CT scan should be performed immediately for further assessment if emphysematous pyelonephritis is suggested. Pyonephrosis Please see the eMedicine article Pyonephrosis for details on this entity. Nephrocalcinosis Medullary nephrocalcinosis is usually associated with hypercalcemic states. Hyperparathyroidism and distal renal tubular acidosis account for more than 60% of cases. The remaining 40% are due to a variety of other causes of hypercalcemia and hypercalciuria, such as Cushing syndrome, sarcoidosis, bone metastasis, furosemide therapy, or excessive dietary calcium and/or oxalate. Both kidneys reveal multiple areas of increased echogenicity involving all the renal pyramids. The renal cortex is normal, and no evidence of hydronephrosis is present. Renal hemorrhage Renal parenchymal bleeding due to trauma or surgery is usually present as a subcapsular hematoma that is echogenic immediately after the hemorrhage but becomes progressively less echogenic as the hematoma resolves. Within days, the appearance is anechoic with a fluid-debris level. Blood within the renal collecting system and hemorrhagic cysts are discussed below. Collecting system masses The differential diagnosis of masses within the renal collecting system includes soft tissue masses such as transitional cell carcinoma (TCC); blood clots; fungus balls; sloughed papilla; fibroepithelial polyps; invasion by renal cell carcinoma, vessel impressions, or metastatic tumors. Other masses include stones and the presence of air.
Renal cysts Cysts are the most common masses found in the kidney. They can occur singly or in multiple numbers and are thought to arise from epithelial overgrowth of tubules or collecting ducts, with resulting distention of the nephrons. The chance of developing renal cysts increases with age. They are very rare in children and uncommon in individuals younger than 40 years, but they are present in 50% of the population older than 55 years. Cysts also tend to enlarge over time and develop thin septations. Ultrasound is the modality of choice when imaging renal cysts. The initial assessment of a possible cyst is a determination of whether it is a fluid-filled, solid, or semisolid mass. A fluid-filled cyst appears anechoic, while a solid cyst or a cyst containing debris appears much more echogenic or shows low-level echoes within the lumen. Also, strong posterior enhancement with an anechoic lumen almost certainly excludes a solid mass. Cysts in the lower pole of the kidney are seen more easily because the ribs are not superimposed. Anterior artifacts within the cyst can be caused by reverberation from the skin-transducer interface. Transducer interface can be suppressed by scanning from opposite approaches.
Solid masses Kidney tumors appear as heterogeneous echogenic masses and may be accompanied by slightly dilated adjacent renal calyces, due to compression of infundibuli. Consider any solid renal mass malignant until it has been proven otherwise. Eighty-five percent of solid renal masses are renal cell carcinoma, while another 10% are due to other malignancies such as renal sarcoma, lymphoma, TCC, or metastases. The remaining 5% are benign and include oncocytoma, angiomyolipoma, and fibroma. Of these, only angiomyolipoma is distinguishable from the others sonographically, due to the presence of the highly echogenic fat within these tumors. Renal transplant sonography The superficial placement of a renal graft in the iliac fossa makes sonographic imaging of this structure easier than imaging native kidneys. Most patients are referred for ultrasound because of deteriorating renal function, as demonstrated by a rise in serum creatinine levels and/or decreased urine output. In the immediate postoperative period, renal vein thrombosis is a major complication, resulting in graft failure. As might be expected, the vascular resistance of the kidney is extremely high, and spectral Doppler tracing shows a rapid, transient peak systolic spike followed by reversed diastolic flow. The primary role of ultrasound in kidneys that have survived the immediate postoperative dangers is to differentiate between ureteral obstruction and systemic causes of reduced function, such as rejection or acute tubular necrosis. In severe rejection, the transplant acutely becomes more echogenic. Swelling is present, hypoechogenicity of the medullary pyramids is seen, the corticomedullary junction is indistinct, and the globular size of the kidney is increased. The size increase is not specific for rejection; it may be seen in persons with pyelonephritis and transplant vein thrombosis. Color Doppler is used to identify the interlobar and arcuate vessels of the transplanted kidney. Indications for Doppler ultrasound in renal transplant recipients include measurement of the resistive index in intrarenal arteries, possible renal vein thrombosis, renal artery stenosis, and renal cortical perfusion. Renal vascular disease The kidneys are highly vascular organs. In their normal state, they show a low resistance to blood flow. Doppler ultrasound has been shown to be useful in hypertension, renal transplantation, and urinary tract obstruction. Primary renal abnormalities are an identifiable cause of hypertension in approximately 4% of patients. Renal artery stenosis occurs in approximately 1-4% of patients with hypertension and is usually due to atheroma or fibromuscular hyperplasia. Doppler ultrasound can help identify renal artery stenosis with examination of the main renal artery or at the intrarenal arterial flow. A spectral Doppler trace from the main renal artery can reveal the typical high-peak velocities of an arterial stenosis. Peak systolic velocities faster than 200 cm/s strongly suggest renal artery stenosis. The upstream narrowing caused by renal artery stenosis results in a damped downstream intrarenal waveform, known as parvus et tardus (small and late). Bladder UltrasoundNormal appearance The full bladder provides a sonographic window for evaluation of the uterus and adnexa and serves to displace bowel gas. On longitudinal view, the full bladder has a teardrop-shaped anechoic appearance, while on the transverse view, it appears rectangular. The thickness of the bladder wall varies with the degree of bladder filling. Masses within the bladder can be diagnosed with relative certainty only if the bladder is full. Infoldings of the wall of an incompletely filled bladder can give the impression of an intraluminal mass. Bladder diverticula Most diverticula are acquired secondary to bladder outlet obstruction from neuropathic voiding dysfunction, prostate enlargement, or strictures of the urethra. Acquired diverticula start as small outpouchings of mucosa that evaginate between hypertrophied detrusor muscle bundles and do not extend past the bladder wall. These small outpouchings are termed cellules. With persistent obstruction, progressive herniation of the bladder mucosa occurs through the detrusor muscle to form a diverticulum. The congenital type of diverticulum, a Hutch diverticulum, develops from herniation of the bladder mucosa through a congenital weakness in the detrusor muscle of the bladder slightly superior and lateral to the ureteral orifice. Occasionally, these can cause obstruction or vesicoureteral reflux (VUR). A bladder diverticulum appears as an anechoic, thin-walled extension from the bladder lumen. The diverticulum can range in shape from teardrop to semicircular, depending on the width of the neck of the diverticulum. Usually, continuity between the bladder and diverticulum can be demonstrated sonographically. If the diverticulum has a narrow neck, infection and stone formation can occur, appearing, respectively, as echogenic debris or a hyperechoic mass with posterior shadowing. Tumors can also occur within the diverticulum because they are lined by uroepithelium. While a small tumor in a diverticulum can occasionally be seen as an irregular mass of medium echogenicity within the diverticular lumen, larger tumors can be difficult to detect sonographically because a diverticulum filled with tumor may be indistinct from the adjacent hypertrophied bladder wall. Ureterocele Ureterocele is a prolapse into the bladder of the intravesical portion of the distal ureter with an associated dilation of the distal ureter. Ureteroceles appear as thin-walled curvilinear structures with an anechoic lumen. When the bladder is filled and the ureterocele is extended, the ureterocele is sonographically reminiscent of a thin septation within the bladder. Orthotopic ureteroceles form in the ureter with a normal insertion into the trigone. They are seen sonographically on the posteroinferior bladder wall. Because of their low posterior location, orthotopic ureteroceles can often be visualized better by TRUS in males or transvaginal ultrasound in females than by transabdominal ultrasound. Orthotopic ureteroceles usually occur in single systems and are usually small, unilateral, and asymptomatic. Ectopic ureteroceles usually occur in duplicated collecting systems and can cause partial or complete obstruction. These are usually located posteriorly, but closer to the midline and further inferiorly than orthotopic ureteroceles. Because of their inferior location, ectopic ureteroceles may not be visible by transabdominal ultrasound because the pubic bone can interfere with the imaging angle. Infection, stone formation, or both can occur within the lumen of the ureterocele and is seen as debris or as a hyperechoic mass with posterior shadowing within the ureterocele, respectively. Bladder masses The classic appearance of TCC within the bladder is of an irregular soft tissue structure of low- to intermediate-echo texture projecting into the bladder lumen from a fixed mural site. Lesions are often branched or frondlike. The attachment to the bladder wall may be either sessile or stalklike. This appearance is indistinguishable sonographically from other neoplasms such as squamous cell carcinoma (SCC) or direct extension into the bladder from prostate, colon, or gynecologic malignancies. Calcification is detected in TCC in fewer than 2% of cases. Bullous edema from inflammation due to cystitis or irritation from a catheter or bladder stone can also appear as an irregular mass but is less echogenic than TCC. Bullous edema may have small anechoic areas, representing edema fluid, within the mass. Carcinoma in situ and squamous metaplasia are generally undetectable by ultrasound but may be seen as focal bladder wall thickening. Bladder volume measurement Bladder volume can be calculated by various geometric formulas with commercially available portable bladder scanners. Bladder volume measurements are generally more accurate if the patient is relaxed and supine. A different formula is used for men and women to allow for the different shape of the bladder between sexes. In a woman who has had a hysterectomy, use the male scanner setting. Prostate UltrasoundNormal appearance Understanding the prostate anatomy is essential to understanding ultrasound images of the prostate. The prostate has 3 anatomic areas or zones. The peripheral zone (PZ) is the posterior and distal portion (the apex) of the gland. This zone is palpable upon digital rectal examination, comprises the bulk of the volume of the normal prostate gland, and is the site of origin of the vast majority of prostate cancers. The central zone (CZ) is a small, cone-shaped zone at the cephalad aspect of the prostate (the base) surrounding the ejaculatory ducts; cancers arising from this zone are quite rare. The TZ is composed of 2 lobes of tissue anteriorly, on either side of the urethra; this zone is the site of origin of benign prostatic hyperplasia (BPH) and approximately 10-20% of prostate cancers; the size of this zone is extremely variable, depending on the degree of BPH. The anatomic distinction between the CZ and PZ is not ordinarily visualized by TRUS, despite the distinctive histologic differences of these zones. The normal CZ and PZ should be a homogeneous light- to medium-gray area occupying the posterior third of the prostate. Relative to these 2 zones, the anteriorly located TZ exhibits moderately heterogeneous hypoechogenicity. BPH nodules in the TZ can be isoechoic or hyperechoic but are most often hypoechoic. This heterogeneity and hypoechogenicity becomes progressively more prominent with increasing volume of BPH and is most likely due to variations in the amount of stromal and glandular elements of the hyperplasia. The TZ may represent as little as 5% of a normal young man's prostate and more than 90% of a prostate with BPH. With increased size of the TZ, the PZ and CZ become progressively compressed posteriorly. Normally, the TZ does not extend past the verumontanum in the middle portion of the prostate. However, the TZ also expands distally as it enlarges, progressively overhanging the apical PZ. BPH often contains single or numerous cystic structures of various sizes. Cysts appear as anechoic (black) smooth-walled, spherical structures with increased through-enhancement. Increased through-enhancement is caused by the ultrasound waves moving rapidly, without reflection through the low-impedance cyst fluid, then abruptly striking the opposite side of the cyst. The time-gain compensation and higher density of sound waves reaching the opposite wall of the cyst and the tissues beyond it make these areas appear brighter than the surrounding tissues. The boundary between the TZ and PZ is the surgical capsule for transurethral prostatectomy and is often sharply demarcated by TRUS as a hypoechoic convex line. With increasing BPH, this boundary becomes less convex. This margin is often peppered with corpora amylacea that are markedly hyperechoic. When more calcified and concentrated, these deposits can completely interrupt the ultrasound waves, causing posterior shadowing (a familiar finding with renal calculi on ultrasound) that obscures some or all of the TZ. Such calcifications have been correlated with a history of prostatitis but are often seen in healthy young men with no history of prostatic inflammation. The preprostatic sphincter, composed of the bladder neck and periurethral tissue, is located between the 2 lobes of the TZ. This structure demonstrates the dramatic hypoechogenicity typical of muscle due to the concentration of smooth muscle fibers. These muscles appear as an inverted Y, which has been termed the Eiffel Tower sign, in the axial plane and as a curved, triangular shape similar to a tornado in the sagittal plane. These muscle fibers often intermingle with the nodules of BPH. The lumen of the prostatic urethra is not usually visible sonographically unless it has been surgically altered, such as with transurethral prostatectomy, or unless it is distended during sonography. When TRUS is performed in preparation for brachytherapy, the urethra is commonly distended with lubricating jelly or a urethral catheter in order to avoid seed placement near the urethra. In the apex, or distal prostate, in the axial plane, the periurethral tissue appears as a hypoechoic-inverted horseshoe. In the sagittal plane, this structure appears tubular and can be followed along its course to the external sphincter and proximal bulbar urethra. The pubic bone demonstrates a hyperechoic margin with dramatic posterior shadowing. The inner margins of the pubic bone can be recognized and compared to the outer margins of the prostate during evaluation for pubic arch interference during prostate brachytherapy. If present, this interference is usually resolved by reducing the prostate volume with preimplant androgen deprivation therapy. The thick muscular wall and fluid-filled lumens of the seminal vesicles, vas deferens, and ejaculatory ducts lend these structures a dark-gray echo pattern. Anterior to the seminal vesicles, the muscular bladder wall is dark gray and of variable thickness. Urine within the bladder is anechoic and can aid in delineating the anterior extent of the prostate and the presence of any median lobe. Due to their predominantly adipose composition, the periprostatic tissues are generally quite echogenic, appearing almost entirely white on ultrasound images. The posterolateral aspect of the prostate margin, where the neurovascular structures enter the gland, are generally dark gray, with areas that are completely anechoic due to the fluid-filled, thin-walled veins. With the patient in left lateral decubitus position, the dependent left neurovascular bundle is often more prominent than the right. The anteromedial venous structure of the dorsal vein complex can also be seen as anechoic, somewhat linear structures, within the white periprostatic adipose. Because the scanner rate for prostate sonography is slow, flow in these vascular structures is generally not apparent. Extending toward the rectum from the dramatic anterior shadowing of the pubic bone, just lateral and distal to the prostate apex, is the levator musculature. This muscle has a distinctive hypoechoic appearance, with hyperechoic parallel streaks representing the adipose-containing fascia separating the muscle bundles. Anatomic variations Villers et al evaluated 100 radical prostatectomy specimens, correlating anatomic variations with ultrasound findings. In 2% of specimens, the seminal vesicles and vas deferens continued caudally as separate structures for more than 5 mm below the cephalad extent of the CZ. On ultrasound images, this variant gives the appearance of bilateral basilar hypoechogenicity. In 12% of patients, abnormal penetration of the seminal vesicles and vas deferens was present at the rectal surface of the prostate, characterized by a lack of CZ tissue posterior to these structures, which sonographically appeared as midline hypoechogenicity at the base of the prostate. In 6% of cases, abnormally large (>2 mm in diameter) smooth muscle bundles were present within the ejaculatory duct sheath, which also produced midline hypoechogenicity at the prostate base on ultrasound imaging. In 3% of patients, the seminal vesicles extended laterally to the prostate gland. Their distal portion was embedded into the stroma of the CZ without any interposition of fibroadipose tissue. This variant was seen as lateral hypoechogenicity at the prostate base on ultrasound images. In 2% of patients, ultrasound revealed a cystic utricle, defined as a utricle lumen larger than 4 mm with loss of epithelial papillations, that appeared sonographically as a midline cystic structure at the base with an anechoic lumen and increased through-enhancement. Prostate volume determination Determination of prostate volume can be useful in treatment planning of both surgery and radiation therapy. Volume measurements can also be valuable in monitoring the response to hormonal treatment or radiation therapy. Volume measurements yield a calculated volume in cubic centimeters. Because the specific gravity of prostate tissue is 1.050, the volume in cubic centimeters is comparable to the weight of the gland in grams. Prostate volume is usually calculated with the assumption that the prostate shape is elliptical (eg, a football); the calculation can be performed by either of two methods. In one method, the prostate image at the widest transverse dimension in the axial plane is outlined with the cursor on the ultrasound console, allowing the computer to calculate the surface area of that section of the prostate. The transverse prostate dimension (from the left to the right side of the gland) at the estimated point of widest transverse dimension is then measured. The prostate volume can then be calculated by the following formula, 8 (surface area) squared, divided by 3p (transverse dimension). Most commercially available ultrasound console computers automatically perform this calculation when in the volume measurement mode. The other, more commonly used method is elliptical volume calculation. This requires measurement of the prostate dimensions. First, dimensions of the prostate are determined in the axial plane by measuring the transverse and anteroposterior dimension of the prostate at the estimated point of widest transverse dimension. The longitudinal dimension is measured in the sagittal plane just off the midline because the bladder neck often obscures the cephalad extent of the gland. The formula, (p/6) (transverse dimension) (anteroposterior dimension) (longitudinal dimension), is then applied to calculate the volume. Because of the inaccuracy of the longitudinal dimension caused by lateral refraction of the ultrasound image, slightly better prostate volume calculation can be accomplished by eliminating this dimension, using the formula for calculating the volume of a prolate spheroid (eg, an egg), (p/6) (transverse dimension) squared (anteroposterior dimension). The prolate spheroid formula is most accurate for glands less than 80 mL in volume; larger prostates assume a more spherical configuration, and their volume is better calculated by the formula for the volume of a sphere, (p/6) (transverse dimension) cubed. Unfortunately, no prostate gland is a perfect sphere, ellipse, or prolate spheroid, which renders all of these calculations somewhat inaccurate. However, all correlate with prostate weight with correlation coefficients higher than 0.90. The most accurate means of prostate volume measurement is planimetry, which allows for variations in shape. In this method, the ultrasound probe is mounted on a stepping device, allowing the probe to be marched through the gland in the axial plane at defined intervals. At each interval, the prostate image is outlined with the cursor on the ultrasound console, allowing the computer to calculate the surface area of that section. Prostate volume is calculated by taking the sum of the prostate image surface areas measured at each step and multiplying this value by the stepping interval. Most stepping devices provide 5- or 2-mm stepping intervals. The shorter the stepping interval, the more accurate the volume calculated. Because of its superior accuracy and reproducibility, this is the method of choice for treatment planning for brachytherapy. The stepping device can also serve to stabilize the ultrasound probe during brachytherapy. Transrectal ultrasound for infertility Transrectal ultrasound is very helpful in the evaluation of the infertile male. It is indicated in men with azoospermia and low ejaculate volume ( <1.5 mL). It is used to evaluate for obstructive causes of infertility by looking for cystic dilation of the ejaculatory ducts and seminal vesicles. The normal seminal vesicle should measure less than 1.5 cm on the anteroposterior view. Ultrasonography of prostatic malignancy Originally hailed as a possible diagnostic modality for prostate cancer, transrectal ultrasound is now known to have limited applicability for initial diagnosis. Malignant lesions in the prostate can be hypoechoic, isoechoic, or hyperechoic.
Appearance following treatment
Appearance of nonadenocarcinoma malignancies
Urethral UltrasoundSonourethrography has been shown to be accurate, sensitive, and specific for the diagnosis and assessment of penile and bulbar urethral strictures. Compared with conventional retrograde urethrograms, sonourethrograms involve no ionizing radiation and potentially can detect spongiofibrosis and other periurethral abnormalities invisible on radiographic urethrograms. However, the applicability of urethral ultrasound has evolved to include planning for surgical approach to urethral stricture disease. Because ultrasound can be used to identify the extent of spongiofibrosis not seen on retrograde urethrogram, many experts recommend preoperative ultrasound prior to reconstructive surgery. Scrotal UltrasoundUltrasound is the imaging method of choice for evaluation of the scrotal contents. Scrotal imaging is usually performed with a 5- or 7.5-MHz small-parts transducer. Testicular imaging
Extratesticular scrotal ultrasound
Fetal urologic ultrasound
Renal neoplasms in the fetus and neonate
PROSTASCINTIGRAPHYCapromab pendetide (ProstaScint) is a murine monoclonal antibody directed against prostate-specific membrane antigen. It reportedly has an affinity for approximately 95% of adenocarcinomas of the prostate. Its primary use is the detection of soft tissue metastases of prostate carcinoma when tagged with indium In 111. Normal biodistribution of capromab pendetide includes the most intense activity in the liver, spleen, bone marrow, and blood pool. Varying levels of activity are observed in the kidneys, nasopharynx, spermatic cord, and genitalia. Prostatic soft tissue metastases are typically located more often in pelvic lymph nodes but are usually more difficult to identify by ProstaScint scanning, due to masking by the bone marrow in the pelvis. As a result, detection of pelvic nodal disease usually requires careful evaluation with tomographic imaging. This evaluation is often performed with dual isotope imaging, using both ProstaScint and tagged red blood cells, which help by localizing the blood pool activity. ProstaScint is currently approved as a diagnostic imaging agent indicated for the staging of patients newly diagnosed with prostate cancer who are at high risk for lymph node metastases. However, capromab pendetide imaging should be reserved for use in newly diagnosed patients with negative bone scan results who are candidates for local therapy with curative intent but who are at high risk for metastatic disease based on clinical stage, Gleason score, and PSA level. A negative result from the scan does not eliminate the need for a staging lymph node dissection but should encourage further pursuit of local treatment options. A positive result from the scan in a high-risk setting supports proceeding with systemic treatment options or watchful waiting. ProstaScint is also indicated in patients with recurrent disease in whom primary therapy for prostate cancer has failed, as determined by rising levels of PSA, but for whom the site of recurrence is unknown. One limitation to widespread use of ProstaScint imaging is the steep learning curve for interpreting images. A few nuclear medicine physicians in large referral centers have adequate experience to reliably provide the clinician with substantial additional information. MAGNETIC RESONANCE IMAGINGPhysics of magnetic resonance imaging The physics of MRI are extremely complex. When a patient is placed in the scanner, the protons in the patient's tissues (primarily protons contained in water molecules) align themselves along the direction of the magnetic field. A radiofrequency electromagnetic pulse is then applied, which deflects the protons off their axis along the magnetic field. As the protons realign themselves with the magnetic field, a signal is produced. This signal is detected by an antenna and, with the help of computer analysis, is converted into an image. The process by which the protons realign themselves with the magnetic field is referred to as relaxation. The protons undergo 2 types of relaxation: T1 (or longitudinal) relaxation and T2 (or transverse) relaxation. Different tissues undergo different rates of relaxation. In T1-weighted images (emphasizing the difference in T1 relaxation times between different tissues), water-containing structures are dark. Because most pathologic processes (eg, tumor, injury, cerebrovascular accident) involve edema (or water), T1-weighted images do not show good contrast between normal and abnormal tissues. However, they do demonstrate excellent anatomic detail. T2-weighted images emphasize the difference in T2 relaxation times between different tissues. Because water is bright in these images, T2-weighted images provide excellent contrast between normal and abnormal tissues, although with less anatomic detail than T1-weighted images. Proton density images emphasize neither T1 nor T2 relaxation times and therefore produce contrast based primarily on the amount of protons present in the tissue. The most important known risk of MRI is the projectile effect, which involves the forceful attraction of ferromagnetic objects to the magnet. Caution also must be exercised in patients with embedded ferromagnetic objects (eg, shrapnel) and in those with implants (eg, pacemaker wires). MRI should not be performed on patients with cardiac pacemakers or aneurysm clips. Magnetic resonance imaging contrast Intravenous contrast is often used to improve the sensitivity of MRI, especially in the brain and spine. Contrast agents contain gadolinium, which increases T1 relaxation and causes certain abnormalities to "light up" on T1-weighted images. Gadolinium, one of the rare earth elements in the transition group IIIb of the periodic table, is found throughout the earth's crust. It has 8 unpaired electrons in its outer shell, which causes its paramagnetic effects. Gadolinium by itself can cause heavy metal poisoning. However, when bound to a chelation agent, it is safe for intravenous injection yet remains paramagnetic. Gadolinium contrast agents have an extraordinarily favorable safety profile. No nephrotoxicity is clinically detectable for the currently available formulations of gadolinium, including gadopentetate dimeglumine (Magnevist; Berlex Imaging, Wayne, NJ), gadoteridol (ProHance; Bracco Diagnostics, Princeton, NJ), or gadodiamide (Omniscan; Nycomed Amersham, Princeton, NJ), even at high doses. In addition, they have a very low frequency of adverse events. Idiosyncratic reactions are rare, and serious adverse events are extremely rare (1 in 20,000). These agents contain no iodine, which is the etiology of most contrast allergies. Gadolinium-based contrast agents (Magnevist, MultiHance, Omniscan, OptiMARK, ProHance) have recently been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). For more information, see the eMedicine topic Nephrogenic Fibrosing Dermopathy. The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or magnetic resonance angiography (MRA) scans. As of late December 2006, the FDA had received reports of 90 such cases. Worldwide, over 200 cases have been reported, according to the FDA. NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness. For more information, see the FDA Public Health Advisory or Medscape. Gadolinium-containing contrast agents usually have no effect on blood chemistry and hematologic studies except transient elevation of serum iron and bilirubin levels. These elevations peak 4-6 hours after injection and return to baseline values in 24-48 hours. The mechanism of these elevations is uncertain but may be related to mild hemolysis. A 10-11% increase in the activated partial thromboplastin time and thrombin time occurs in vitro with the inhibition of platelet aggregation. Less platelet aggregation inhibition is observed than with iodinated ionic contrast material, and no bleeding problems are reported clinically. Note that important contraindications to gadolinium MRI include pregnancy and a history of a life-threatening reaction to gadolinium itself. Patients with poor renal function may have delayed excretion of gadolinium contrast agents. Magnetic resonance angiography Magnetic resonance angiography can be useful to urologists to determine the vascular supply to potential living-related donor kidneys, renal masses planned for partial nephrectomy, or crossing vessels in ureteropelvic junction obstruction. With intravenous injection, gadolinium is initially in the arm vein, then the pulmonary circulation, and then the arteries; eventually, it is distributed throughout the circulatory system. Within a few minutes, gadolinium is redistributed into the extracellular fluid space. To make blood bright compared with all background tissues, a sufficient dose of gadolinium is necessary. Approximately 0.3 mmol/kg gadolinium is usually sufficient for an average or heavy person when imaging in the equilibrium phase. However, arteries are best imaged during the arterial phase of gadolinium infusion. Renal masses For patients with renal insufficiency or prior severe allergic reaction to iodinated contrast material, MRI with gadolinium and fast-imaging techniques are alternatives to contrast-enhanced CT scan. MRI provides sensitivity similar to that of CT scan in detecting contrast enhancement of suggestive renal masses. In addition, the multiplanar reconstruction capabilities of MRI can provide supplemental information on the nature of the mass from alternate angles. Transitional cell carcinoma For TCC involving the upper urinary tract, MRI is generally accurate in staging but may not detect direct invasion of the renal parenchyma. The degree of invasion into the bladder in cases of lower tract TCC is detected more easily by MRI, but the extent of disease is often overestimated. Prostate cancer MRI for the evaluation of prostate cancer can be performed with standard MRI instrumentation, but superior prostate definition is produced when MRI is performed with an endorectal surface coil within an inflated latex balloon positioned in the rectum. MRI produces superior staging information for seminal vesicle involvement compared to all other imaging techniques. Some authors report that when extracapsular tumor extension into periprostatic fat, periprostatic venous plexus, seminal vesicles, and lymph nodes is evaluated, MRI has a sensitivity of 87%, a specificity of 90%, and an accuracy of 89%. However, most investigators believe that the staging information from MRI does not provide added information over the results available from prostate biopsy pathology and PSA data. When in error, MRI tends to overstage the tumor. Adrenal masses CT scan remains the primary procedure for evaluating the adrenal glands. MRI is useful for evaluating adrenal masses in cancer patients because it often reveals differences between metastases and the common, incidentally discovered benign adrenal adenomas. MRI is the best imaging test for diagnosing and staging pheochromocytoma, which usually (but not always) demonstrates high signal intensity, appearing as a bright "light bulb" on T2-weighted MRI. Metastatic disease MRI enables the detection of abnormalities that might be obscured by bone with other imaging methods. Thus, it is the method of choice for imaging spinal metastases when early or impending spinal cord compression is a concern. For nodal disease, MRI is an alternative for patients with renal insufficiency or prior severe allergic reaction to iodinated contrast material who are undergoing evaluation for nodal spread of prostate cancer, renal cell carcinoma, and TCC. MRI is particularly useful for nodal disease above the diaphragm. MRI is superior to CT scan for the detection of nodal metastases from seminoma and embryonal cell carcinoma, with a sensitivity of 87%. Vesicoureteral reflux MRI is used for evaluating VUR, differential renal function, and renal scarring in children without exposing the patient to radiation. MRI combines the information obtained from functional nuclear scans, vesicoureterogram, and ultrasound in a single study. Coronal T1-weighted and axial T1- and T2-weighted images without contrast media are performed, followed by insertion of contrast medium into the bladder through a catheter. Next, intravenous contrast medium is administered. Coronal T1-weighted and axial T1- and T2-weighted images are then repeated, and gradient-recalled echo images are repeatedly collected. MRI for VUR provides measures of differential renal function similar to nuclear imaging and is superior to other methods for evaluating renal scarring. NUCLEAR MEDICINE |